A 25-year-old client who is taking fluoxetine (Prozac)to treat depression reports decreased sexual desire since starting the medication. What can the nurse anticipate with regard to changes in the client's pharmacological regimen?

Question

Quizplus · Accepted Answer

A)SSRI antidepressants, including both fluoxetine (Prozac)and paroxetine (Paxil), are frequently associated with a range of sexual side effects, including reduced desire. Abrupt discontinuation of these medications is not advisable because it can exacerbate a client's depression. Instead, providers may prescribe the atypical antidepressant bupropion (Wellbutrin)along with SSRI therapy, as bupropion can exert desire-increasing effects. Although flibanserin is the only FDA-approved medication specifically aimed at the treatment of low desire in women, it is rarely prescribed and would not be a provider's first treatment option in this scenario.
B)SSRI antidepressants, including both fluoxetine (Prozac)and paroxetine (Paxil), are frequently associated with a range of sexual side effects, including reduced desire. Abrupt discontinuation of these medications is not advisable because it can exacerbate a client's depression. Instead, providers may prescribe the atypical antidepressant bupropion (Wellbutrin)along with SSRI therapy, as bupropion can exert desire-increasing effects. Although flibanserin is the only FDA-approved medication specifically aimed at the treatment of low desire in women, it is rarely prescribed and would not be a provider's first treatment option in this scenario.
C)SSRI antidepressants, including both fluoxetine (Prozac)and paroxetine (Paxil), are frequently associated with a range of sexual side effects, including reduced desire. Abrupt discontinuation of these medications is not advisable because it can exacerbate a client's depression. Instead, providers may prescribe the atypical antidepressant bupropion (Wellbutrin)along with SSRI therapy, as bupropion can exert desire-increasing effects. Although flibanserin is the only FDA-approved medication specifically aimed at the treatment of low desire in women, it is rarely prescribed and would not be a provider's first treatment option in this scenario.
D)SSRI antidepressants, including both fluoxetine (Prozac)and paroxetine (Paxil), are frequently associated with a range of sexual side effects, including reduced desire. Abrupt discontinuation of these medications is not advisable because it can exacerbate a client's depression. Instead, providers may prescribe the atypical antidepressant bupropion (Wellbutrin)along with SSRI therapy, as bupropion can exert desire-increasing effects. Although flibanserin is the only FDA-approved medication specifically aimed at the treatment of low desire in women, it is rarely prescribed and would not be a provider's first treatment option in this scenario.

A 25-Year-Old Client Who Is Taking Fluoxetine (Prozac)to Treat Depression